AbstractAdenocarcinoma of the prostate (CAP) is a rare diagnosis in men younger than 50 years of age; this age group accounts for less than 0.1% of all patients with prostatic cancer. Left supraclavicular lymphadenopathy (LSCL) as the presenting symptom of metastatic CAP is even rarer. No cases of CAP presenting as LSCL in men younger than 45 years have been reported in the literature. Here we report a 42-year-old male with the uncommon presentation of CAP as LSCL. In adult males with persistent LSCL, even if younger than 45 years, measurement of serum prostate specific antigen is warranted at the time of initial presentation, and the lymph node biopsy should be subsequently stained for prostate specific antigen immunohistochemically. These...
We report a rare case of a primary malignant lymphoma of the prostate, which presented as urinary re...
Three patients with prostate cancer and left cervical lymph node metastasis are presented. The three...
Prostate cancer is the most common malignancy in men. The 5-year relative survival for all stages co...
Adenocarcinoma of the prostate (CAP) is a rare diagnosis in men younger than 50 years of age; this a...
AbstractAdenocarcinoma of the prostate (CAP) is a rare diagnosis in men younger than 50 years of age...
Aims:Patients presenting with a neck mass are commonly seen by the ENT surgeon. They are also usual...
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction...
Prostate cancer usually metastasis to the regional lymph nodes and can rarely metastases to nonregio...
The most common method of spreading of prostate cancer is via direct invasion to the pelvic organs o...
Prostate cancer is predominantly a disease of older men. Patients generally present with urinary sym...
AbstractProstate cancer typically metastasizes to bones and regional lymph nodes. Generalized lympha...
Prostatic adenocarcinoma is the most common cancer in men, and is the 3rd leading cause of death in ...
Prostate cancer in its advanced form usually metastasizes to the bone or pelvic ganglia. The involve...
Prostate carcinoma occurs infrequently in patient less than 50 years old with an incidence of 0.8% t...
Prostatic carcinoma initially manifesting as only cervical lymph node swelling is a rare phenomenon....
We report a rare case of a primary malignant lymphoma of the prostate, which presented as urinary re...
Three patients with prostate cancer and left cervical lymph node metastasis are presented. The three...
Prostate cancer is the most common malignancy in men. The 5-year relative survival for all stages co...
Adenocarcinoma of the prostate (CAP) is a rare diagnosis in men younger than 50 years of age; this a...
AbstractAdenocarcinoma of the prostate (CAP) is a rare diagnosis in men younger than 50 years of age...
Aims:Patients presenting with a neck mass are commonly seen by the ENT surgeon. They are also usual...
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction...
Prostate cancer usually metastasis to the regional lymph nodes and can rarely metastases to nonregio...
The most common method of spreading of prostate cancer is via direct invasion to the pelvic organs o...
Prostate cancer is predominantly a disease of older men. Patients generally present with urinary sym...
AbstractProstate cancer typically metastasizes to bones and regional lymph nodes. Generalized lympha...
Prostatic adenocarcinoma is the most common cancer in men, and is the 3rd leading cause of death in ...
Prostate cancer in its advanced form usually metastasizes to the bone or pelvic ganglia. The involve...
Prostate carcinoma occurs infrequently in patient less than 50 years old with an incidence of 0.8% t...
Prostatic carcinoma initially manifesting as only cervical lymph node swelling is a rare phenomenon....
We report a rare case of a primary malignant lymphoma of the prostate, which presented as urinary re...
Three patients with prostate cancer and left cervical lymph node metastasis are presented. The three...
Prostate cancer is the most common malignancy in men. The 5-year relative survival for all stages co...